NCT05075616

Brief Summary

The application of PEG in geriatric-palliative care has not been well discussed. With the development of endoscopic procedures and PEG devices, we can perform this minimally invasive method more safely, even in challenging cases. We should discuss the indications of PEG in the field of palliative care of geriatric patients. The presented study evaluated geriatric (\> 65-year-old) palliative care patients to whom PEG applied at our institution.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2017

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2017

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 13, 2021

Completed
Last Updated

October 13, 2021

Status Verified

October 1, 2021

Enrollment Period

3.2 years

First QC Date

October 2, 2021

Last Update Submit

October 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Weight and body mass index changes

    Evaluation of weight and body mass index changes after Percutaneous endoscopic gastrostomy tube application

    30 days

Interventions

Percutaneous endoscopic gastrostomy (PEG) is a minimally-invasive endoscopic procedure that creates a passage from the patient's stomach to the abdominal wall via a feeding tube and provides a means of feeding if oral intake is not adequate.

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We retrospectively assessed the medical data of PEG applied \>65-year-old patients at our institution between December 2017 and March 2021. And, we excluded the patients who were not treated in our palliative care center. Table 1. shows the contraindications for PEG placement.

You may qualify if:

  • \- We retrospectively assessed the medical datum of PEG applied \>65-year-old patients at our institution between December 2017 and March 2021 in our clinic.

You may not qualify if:

  • We excluded the patients who were not treated in our palliative care center.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Okan University Hospital

Istanbul, 34734, Turkey (Türkiye)

Location

Okan University

Istanbul, 34734, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Nutrition Disorders

Condition Hierarchy (Ancestors)

Nutritional and Metabolic Diseases

Study Officials

  • Murat Ferhat Ferhatoglu, MD

    Okan

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 2, 2021

First Posted

October 13, 2021

Study Start

December 1, 2017

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

October 13, 2021

Record last verified: 2021-10

Locations